Publications by authors named "Remco Diab"

Claim this Profile
P
Population Pharmacokinetics and Exposure-Response Analyses of Sarilumab in Patients with Polymyalgia Rheumatica.
Christine Xu, William S Denney, Ying Liu, Jennifer Sloane, Remco Diab

J Clin Pharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study.
David J Kuter, Waleed Ghanima, Nichola Cooper, Howard A Liebman, Lei Zhang, Remco Diab

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.
Nichola Cooper, A J Gerard Jansen, Robert Bird, Jiří Mayer, Michelle Sholzberg, Remco Diab

Am J Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a postmarketing surveillance study.
Hideto Kameda, Sadatomo Tasaka, Toshiya Takahashi, Katsuhisa Suzuki, Naoki Soeda, Remco Diab

Mod Rheumatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the canonical beta-catenin pathway by histamine.
Sander H Diks, James C Hardwick, Remco M Diab, Marije M van Santen, Henri H Versteeg

J Biol Chem· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis